Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Irani

Showing results (71-80 of 169) with videos related to

Pageof 17
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 1, 1993
[Percutaneous nephrolithotomy after failure of extracorporeal shockwave lithotripsy. Indications, results, perspectives]D Bon, B Doré, F Fournier, et al.
The Journal of Urology|May 1, 1995
Systematic removal of catheter 48 hours following transurethral resection and 24 hours following transurethral incision of prostate: a prospective randomized analysis of 213 patientsJ Irani, A Fauchery, B Dore, et al.
The Journal of Urology|January 1, 1997
Serum-to-urinary prostate specific antigen ratio: its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng./mlJ Irani, C Millet, P Levillain, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 1, 1995
[Results of extracorporeal lithotripsy with ultrasonography-guided hydroelectric lithotriptor: study on 546 patients, prognosis factors]D Bon, B Doré, J Irani, et al.
European Urology|January 1, 1996
Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancerJ Irani, C Millet, P Levillain, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2022
[Assessment of positive surgical margins in the management of patients after radical prostatectomy for pT2 prostate cancer]E Saïer, U Pinar, A De La Taille, et al.
BJU International|September 1, 1999
Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stentsJ Irani, J Siquier, C Pirès, et al.
European Urology|March 29, 2001
Renal tumor size: comparison between computed tomography and surgical measurementsJ Irani, M Humbert, B Lecocq, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 26, 2011
[Survival is associated with time to reach PSA nadir (DAN) and the ratio DAN/nadir value after androgen deprivation for prostate cancer]A Gagnat, S Larré, G Fromont, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2010
[Pelvic lymph nodes dissection for prostate cancer: Minilap with speculum vs laparoscopy]B Merlet, F Ouaki, C Pirès, et al.
Pageof 17

Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 1, 1993
[Percutaneous nephrolithotomy after failure of extracorporeal shockwave lithotripsy. Indications, results, perspectives]D Bon, B Doré, F Fournier, et al.
The Journal of Urology|May 1, 1995
Systematic removal of catheter 48 hours following transurethral resection and 24 hours following transurethral incision of prostate: a prospective randomized analysis of 213 patientsJ Irani, A Fauchery, B Dore, et al.
The Journal of Urology|January 1, 1997
Serum-to-urinary prostate specific antigen ratio: its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng./mlJ Irani, C Millet, P Levillain, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 1, 1995
[Results of extracorporeal lithotripsy with ultrasonography-guided hydroelectric lithotriptor: study on 546 patients, prognosis factors]D Bon, B Doré, J Irani, et al.
European Urology|January 1, 1996
Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancerJ Irani, C Millet, P Levillain, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2022
[Assessment of positive surgical margins in the management of patients after radical prostatectomy for pT2 prostate cancer]E Saïer, U Pinar, A De La Taille, et al.
BJU International|September 1, 1999
Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stentsJ Irani, J Siquier, C Pirès, et al.
European Urology|March 29, 2001
Renal tumor size: comparison between computed tomography and surgical measurementsJ Irani, M Humbert, B Lecocq, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 26, 2011
[Survival is associated with time to reach PSA nadir (DAN) and the ratio DAN/nadir value after androgen deprivation for prostate cancer]A Gagnat, S Larré, G Fromont, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2010
[Pelvic lymph nodes dissection for prostate cancer: Minilap with speculum vs laparoscopy]B Merlet, F Ouaki, C Pirès, et al.
Pageof 17